Drospirenone, a progestin with added value for hypertensive postmenopausal women

Menopause. 2007 May-Jun;14(3 Pt 1):352-4. doi: 10.1097/gme.0b013e31804d440b.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Androstenes / therapeutic use*
  • Coronary Disease / prevention & control
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Estradiol / therapeutic use
  • Estrogen Replacement Therapy
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / prevention & control
  • Mineralocorticoid Receptor Antagonists / therapeutic use*
  • Postmenopause / metabolism*
  • Progestins / therapeutic use*
  • Treatment Outcome

Substances

  • Androstenes
  • Mineralocorticoid Receptor Antagonists
  • Progestins
  • Estradiol
  • drospirenone